Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...
Saved in:
Main Authors: | Sorim Choung, Kyong Hye Joung, Bo Ram You, Sang Ki Park, Hyun Jin Kim, Bon Jeong Ku |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2018/4292509 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wet pulverization combined with temperature cycling strategy for extraction of Stropharia rugosoannulata protein with attenuating hepatic steatosis on obese mice
by: Peng Liu, et al.
Published: (2025-01-01) -
Liver-innervating vagal sensory neurons are indispensable for the development of hepatic steatosis and anxiety-like behavior in diet-induced obese mice
by: Jiyeon Hwang, et al.
Published: (2025-01-01) -
Betaine Treatment Attenuates Chronic Ethanol-Induced Hepatic Steatosis and Alterations to the Mitochondrial Respiratory Chain Proteome
by: Kusum K. Kharbanda, et al.
Published: (2012-01-01) -
Theasinensin A attenuated diabetic development by restoring glucose homeostasis, improving hepatic steatosis and modulating gut microbiota in high-fat-diet/streptozotocin-induced diabetic mice
by: Weiqi Xu, et al.
Published: (2023-11-01) -
Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway
by: Canghai Guan, et al.
Published: (2025-01-01)